J&J announced earnings per share of $2.2 on revenue of $21.08B. Analysts polled by Investing.com anticipated EPS of $1.96 on revenue of $20.15B.
J&J shares are up 4% from the beginning of the year, still down 3.29% from its 52 week high of $157.00 set on April 23. They are outperforming the Dow Jones which is up 1.05% from the start of the year.
J&J’s report follows an earnings missed by Oak Street Health on September 16, who reported EPS of $-72.53 on revenue of $214.38M, compared to forecasts EPS of $-0.12 on revenue of $214.32M.
Helen of Troy Ltd had beat expectations on Thursday with second quarter EPS of $3.77 on revenue of $530.85M, compared to forecast for EPS of $2.38 on revenue of $439.88M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
